Long-Term Proton Pump Inhibitor Use Not Linked to Gastric Adenocarcinoma

FRIDAY, Jan. 23, 2026-- Long-term proton pump inhibitor (PPI) use seems not to be associated with an increased risk for gastric adenocarcinoma, according to a study published online Jan. 21 in The BMJ.Onyinyechi Duru, from Karolinska University...